Truist Financial Reaffirms “Hold” Rating for OrthoPediatrics (NASDAQ:KIDS)

Truist Financial restated their hold rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $30.00 target price on the stock, down from their previous target price of $35.00.

Several other research firms have also issued reports on KIDS. JMP Securities reissued a market outperform rating and issued a $50.00 target price on shares of OrthoPediatrics in a report on Tuesday, May 7th. Needham & Company LLC increased their target price on shares of OrthoPediatrics from $37.00 to $42.00 and gave the stock a buy rating in a report on Tuesday, May 7th.

OrthoPediatrics Price Performance

Shares of NASDAQ:KIDS opened at $26.91 on Thursday. The firm’s 50 day moving average price is $30.73 and its 200-day moving average price is $29.76. OrthoPediatrics has a twelve month low of $23.10 and a twelve month high of $40.22. The company has a quick ratio of 1.99, a current ratio of 4.45 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $641.24 million, a PE ratio of -28.03 and a beta of 1.19.

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors have recently added to or reduced their stakes in the stock. Millrace Asset Group Inc. purchased a new stake in OrthoPediatrics during the 4th quarter valued at approximately $1,283,000. Brown Advisory Inc. grew its holdings in shares of OrthoPediatrics by 1.6% in the fourth quarter. Brown Advisory Inc. now owns 1,628,779 shares of the company’s stock valued at $52,952,000 after purchasing an additional 25,337 shares in the last quarter. Wasatch Advisors LP grew its holdings in shares of OrthoPediatrics by 21.2% in the first quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock valued at $14,618,000 after purchasing an additional 87,657 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of OrthoPediatrics by 649.0% in the second quarter. Harbor Capital Advisors Inc. now owns 67,057 shares of the company’s stock valued at $1,929,000 after purchasing an additional 58,104 shares in the last quarter. Finally, Kennedy Capital Management LLC purchased a new position in shares of OrthoPediatrics in the first quarter valued at $2,894,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.